Form 4: Abeona Therapeutics CFO Joseph Vazzano Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Joseph Vazzano, CFO of Abeona Therapeutics, disposed of 6,388 shares of common stock on September 28, 2024, to satisfy tax withholding obligations upon the vesting of restricted stock.
Summary
- On September 28, 2024, Joseph Vazzano, the Chief Financial Officer of Abeona Therapeutics, disposed of 6,388 shares of common stock.
- The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock.
- The shares were disposed of at a price of $5.89 per share.
- Following the transaction, Vazzano directly owns 365,217 shares of Abeona Therapeutics.
- The disposition is exempt under Rule 16b-3(e) as it relates to tax withholding.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to tax obligations, which is neutral in sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to vesting equity.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 09/28/2024 | Date of the stock disposal transaction. |
| 09/30/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.